Published in Virol J on May 15, 2011
Claudins and the modulation of tight junction permeability. Physiol Rev (2013) 2.05
Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome. Dis Markers (2015) 0.79
Systems Proteomics View of the Endogenous Human Claudin Protein Family. J Proteome Res (2016) 0.79
Alternate Phosphorylation/O-GlcNAc Modification on Human Insulin IRSs: A Road towards Impaired Insulin Signaling in Alzheimer and Diabetes. Adv Bioinformatics (2014) 0.77
Hypotonic Stress-induced Down-regulation of Claudin-1 and -2 Mediated by Dephosphorylation and Clathrin-dependent Endocytosis in Renal Tubular Epithelial Cells. J Biol Chem (2016) 0.77
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res (2003) 52.80
I-TASSER server for protein 3D structure prediction. BMC Bioinformatics (2008) 18.28
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol (1999) 15.63
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) 9.52
The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res (2004) 8.23
Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics (2004) 7.76
The tight junction: a multifunctional complex. Am J Physiol Cell Physiol (2004) 6.13
Proteomic analysis of post-translational modifications. Nat Biotechnol (2003) 5.87
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol (2002) 5.51
Epidemiology of hepatitis C. Hepatology (1997) 4.90
Claudins and epithelial paracellular transport. Annu Rev Physiol (2006) 4.79
Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics (2004) 4.44
A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct Biol (2009) 3.56
KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res (2005) 3.28
Hepatocellular carcinoma and hepatitis C in the United States. Hepatology (2002) 3.00
RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem (1993) 2.68
Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput (2002) 2.29
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol (2002) 2.22
Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol (2002) 2.18
Biology of claudins. Am J Physiol Renal Physiol (2008) 2.17
Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A (2004) 2.10
O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem (2000) 1.98
The claudins. Genome Biol (2009) 1.76
The emerging significance of O-GlcNAc in cellular regulation. Chem Rev (2002) 1.65
Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc Natl Acad Sci U S A (1991) 1.60
Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem (2005) 1.49
Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J Biol Chem (1992) 1.43
EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. J Biol Chem (2005) 1.43
Hepatitis C virus entry into host cells. Cell Mol Life Sci (2008) 1.40
Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem (2006) 1.40
Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol (2005) 1.36
Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J Biol Chem (2001) 1.33
Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res (2003) 1.22
Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid (2006) 1.21
GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol (2006) 1.21
The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. J Membr Biol (2004) 1.19
Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res (2004) 1.13
Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells. Exp Cell Res (2007) 1.12
Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions. J Cell Sci (2006) 1.11
Claudins upregulation in human colorectal cancer. FEBS Lett (2005) 1.10
PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci (2009) 1.08
theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther (2005) 1.04
Tight-junction protein zonula occludens 2 is a target of phosphorylation by protein kinase C. Biochem J (2001) 1.03
Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res (2004) 1.02
O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation? Biochem Biophys Res Commun (1997) 0.95
New aspects of the molecular constituents of tissue barriers. J Neural Transm (Vienna) (2010) 0.93
Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells. Invest Ophthalmol Vis Sci (2009) 0.83
In silico modulation of HMGN-1 binding to histones and gene expression by interplay of phosphorylation and O-GlcNAc modification. Protein Pept Lett (2008) 0.82
CREB in long-term potentiation in hippocampus: role of post-translational modifications-studies In silico. J Cell Biochem (2011) 0.81
Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3. J Cell Biochem (2008) 0.81
Intracellular glycosylation and development. Biochim Biophys Acta (2002) 0.78
Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J Neurosci (2005) 2.05
Tumor-derived p53 mutants induce NF-kappaB2 gene expression. Mol Cell Biol (2005) 1.54
Modulation of gene expression by tumor-derived p53 mutants. Cancer Res (2004) 1.52
HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol (2010) 1.14
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers. Virol J (2011) 0.99
A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol (2011) 0.96
Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virol J (2011) 0.92
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b. Virol J (2011) 0.89
Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs. Virol J (2010) 0.88
RNAi as a new therapeutic strategy against HCV. Biotechnol Adv (2009) 0.87
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J (2011) 0.85
The association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani population. Mol Vis (2010) 0.84
Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). Bioorg Med Chem Lett (2006) 0.84
Association of laboratory parameters with viral factors in patients with hepatitis C. Virol J (2011) 0.83
Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes. Arch Virol (2010) 0.83
Using in vitro models for expression profiling studies on ethanol and drugs of abuse. Addict Biol (2005) 0.83
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV. Virol J (2011) 0.82
Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases. Am J Surg Pathol (2015) 0.81
Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Arch Virol (2010) 0.81
Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA. Virol J (2011) 0.80
HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a. Virol J (2011) 0.80
A situational analysis of HIV and AIDS in Pakistan. Virol J (2011) 0.80
HCV entry receptors as potential targets for siRNA-based inhibition of HCV. Genet Vaccines Ther (2011) 0.79
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med (2012) 0.78
Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs. Virol J (2011) 0.77
Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line. Virol J (2011) 0.77
Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma. Virol J (2011) 0.77
Stable Huh-7 cell lines expressing non-structural proteins of genotype 1a of hepatitis C virus. J Virol Methods (2013) 0.77
Human linker histones: interplay between phosphorylation and O-β-GlcNAc to mediate chromatin structural modifications. Cell Div (2011) 0.77
Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target. Liver Int (2011) 0.76
Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell. Virol J (2012) 0.75
Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO). J Transl Med (2011) 0.75
Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome. Asian Pac J Cancer Prev (2012) 0.75
Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17alpha-hydroxylase/17,20-lyase (P-450(17alpha)). Bioorg Med Chem Lett (2009) 0.75
Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17alpha-hydroxylase/17,20-lyase (P45017alpha) derived from rat testicular microsomes. Bioorg Med Chem Lett (2010) 0.75
Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). J Steroid Biochem Mol Biol (2008) 0.75
Exploration of respiratory chain of Nocardia asteroides: purification of succinate quinone oxidoreductase. J Membr Biol (2012) 0.75
Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome. Asian Pac J Cancer Prev (2012) 0.75